Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07130253
NA

Efficacy of Vonoprazan-based Rescue Therapy for H. Pylori Eradication

Sponsor: National Taiwan University Hospital

View on ClinicalTrials.gov

Summary

1. This study aims to compare the efficacy of empirical vonoprazan-based therapy versus susceptibility-guided vonoprazan-based therapy for third-line eradication of H. pylori. 2. We also plan to explore the impact of eradication therapy on gut microbiota, fecal antibiotic resistance, and metabolic parameters before and after treatment.

Key Details

Gender

All

Age Range

20 Years - Any

Study Type

INTERVENTIONAL

Enrollment

220

Start Date

2025-08-18

Completion Date

2030-06-30

Last Updated

2025-08-19

Healthy Volunteers

No

Interventions

DRUG

Vonoprazan based ET

Empirical therapy Based on drug history: Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or quadruple therapy

DRUG

Vonoprazan based SGT

Susceptibility testing guided therapy Based onsusceptibility test:Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or rifabutin quadruple therapy

Locations (1)

National Taiwan University Hospital

Taipei, Taiwan